Publications by authors named "A Thiry"

Claim this Profile
E
Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose-ranging, double-blind, randomized controlled trial.
Koichi Ikeda, Yasuhiko Matsumori, Masako Kudo, Tomofumi Ishikawa, Yuko Hoshino, Alexandra Thiry

Headache· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plain Language Summary Publication: Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial.
Shigekazu Kitamura, Yasuhiko Matsumori, Toshimasa Yamamoto, Tomofumi Ishikawa, Yuko Hoshino, Alexandra Thiry

Headache· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rimegepant for acute treatment of migraine in triptan-unsuitable adults: A randomized, double-blind, placebo-controlled phase 4 trial.
Messoud Ashina, Peter McAllister, Charly Gaul, Adolfo Leyva-Rendon, Luz M Ramirez, Alexandra Thiry

Cephalalgia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 4, randomized, double-blind, placebo-controlled trial evaluating the efficacy and tolerability of rimegepant for the prevention of episodic migraine in adults with a history of inadequate response to traditional oral preventive medications.
Patricia Pozo-Rosich, José Antonio Gien López, Pawel Lisewski, Ayşe Neslihan Aslan, Harpreet Seehra, Alexandra Thiry

Cephalalgia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 52-week open-label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine.
David Kudrow, Robert S Croop, Alexandra Thiry, Richard B Lipton

Headache· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis